Literature DB >> 20173340

The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond.

Jack C de la Torre1.   

Abstract

The vascular hypothesis of Alzheimer's disease (AD) which we first proposed in 1993, has become a useful concept in identifying vascular risk factors for AD or vascular dementia that can be modified through appropriate treatment to prevent, reduce or delay the onset of cognitive impairment and dementia onset. Among the more than two dozen vascular risk factors already identified for AD, are cardiovascular disease and carotid artery atherosclerosis, which may exert their pathology by chronically lowering cerebral hypoperfusion during aging. We propose and plan to initiate a clinical study to screen middle-aged, cognitively intact individuals, with carotid artery ultrasound and echocardiography to identify potentially progressive pathology in the heart and carotid artery that is considered modifiable with optimal medical treatment. This clinical strategy, if found effective in preventing pathologic conditions suspected of contributing to severe cognitive impairment, could significantly reduce AD prevalence if applied on a wide scale and help promote healthier mental and physical aging while providing a compelling economic benefit to society. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20173340     DOI: 10.1159/000285520

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  60 in total

Review 1.  Tea and cognitive health in late life: current evidence and future directions.

Authors:  J Song; H Xu; F Liu; L Feng
Journal:  J Nutr Health Aging       Date:  2012-01       Impact factor: 4.075

Review 2.  Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.

Authors:  Puneet Talwar; Juhi Sinha; Sandeep Grover; Chitra Rawat; Suman Kushwaha; Rachna Agarwal; Vibha Taneja; Ritushree Kukreti
Journal:  Mol Neurobiol       Date:  2015-09-09       Impact factor: 5.590

3.  The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy.

Authors:  Akihiko Shiino; Toshiyuki Watanabe; Yoshitomo Shirakashi; Emi Kotani; Masahiro Yoshimura; Shigehiro Morikawa; Toshiro Inubushi; Ichiro Akiguchi
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-08       Impact factor: 6.200

4.  Apolipoprotein ɛ4 Allele and Subjective Cognitive Functioning in Parents of Adults With Disabilities.

Authors:  Jieun Song; Marsha R Mailick; Jan S Greenberg
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-09-14       Impact factor: 4.077

5.  Cardiorespiratory fitness modifies the relationship between myocardial function and cerebral blood flow in older adults.

Authors:  Nathan F Johnson; Brian T Gold; Alison L Bailey; Jody L Clasey; Jonathan G Hakun; Matthew White; Doug E Long; David K Powell
Journal:  Neuroimage       Date:  2015-05-30       Impact factor: 6.556

6.  MRI of cerebral micro-vascular flow patterns: A multi-direction diffusion-weighted ASL approach.

Authors:  J A Wells; D L Thomas; T Saga; J Kershaw; I Aoki
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

7.  Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients.

Authors:  Stefan Busse; Mandy Busse; Britta Brix; Christian Probst; Axel Genz; Bernhard Bogerts; Winfried Stoecker; Johann Steiner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-03-07       Impact factor: 5.270

Review 8.  Getting to the Heart of Alzheimer Disease.

Authors:  Joshua M Tublin; Jeremy M Adelstein; Federica Del Monte; Colin K Combs; Loren E Wold
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

9.  Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.

Authors:  Ricardo S Osorio; Indu Ayappa; Janna Mantua; Tyler Gumb; Andrew Varga; Anne M Mooney; Omar E Burschtin; Zachary Taxin; Emmanuel During; Nicole Spector; Milton Biagioni; Elizabeth Pirraglia; Hiuyan Lau; Henrik Zetterberg; Kaj Blennow; Shou-En Lu; Lisa Mosconi; Lidia Glodzik; David M Rapoport; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2013-12-27       Impact factor: 4.673

10.  Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease.

Authors:  Quan Zhang; Randall B Stafford; Ze Wang; Steven E Arnold; David A Wolk; John A Detre
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.